DISCONTINUATION OF CORTICOSTEROIDS AMONG CROHN'S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB IN THE UNITED STATES (US)

被引：1
|
作者：
Patel, Haridarshan
Chastek, Benjamin
Null, Kyle D.
Demuth, Dirk
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31566-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1931
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [1] Discontinuation of corticosteroids among Crohn's disease patients treated with vedolizumab in the United States
    Patel, H.
    Chastek, B.
    Null, K. D.
    Demuth, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S350 - S350
  • [2] DISCONTINUATION OF CORTICOSTEROIDS AMONG ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB IN THE UNITED STATES (US)
    Patel, Haridarshan
    Chastek, Benjamin
    Null, Kyle D.
    Demuth, Dirk
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S396 - S397
  • [3] Discontinuation of corticosteroids among ulcerative colitis patients treated with vedolizumab in the United States
    Patel, H.
    Chastek, B.
    Null, K. D.
    Demuth, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S245 - S246
  • [4] Hospitalizations and Characteristics of Patients with Ulcerative Colitis and Crohn's Disease Treated with Vedolizumab in the United States
    Reynolds, Matthew
    Raluy-Callado, Mireia
    O'Hara, Don
    Alam, Naufil
    Smyth, Michael
    Khalid, Mona
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 : S17 - S17
  • [5] Payer addressable burden of Crohn's disease in patients treated with ustekinumab and vedolizumab in the United States
    Ghosh, T.
    Smith, I.
    Fehr, J.
    Davidson, J.
    Fan, T.
    Candela, N.
    Tsang, C.
    Koch, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S461 - S462
  • [6] Hospitalizations and Treatment Discontinuation among Patients with Ulcerative Colitis and Crohn's Disease Treated with Vedolizumab Compared with Infliximab
    Khalid, Javaria Mona
    Raluy-Callado, Mireia
    Alam, Naufi L.
    Wang, Rosa
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S317 - S317
  • [7] Five Crohn's Disease Patients Treated With Vedolizumab for Pyoderma Gangrenosum
    Groudan, Kevin
    Gupta, Kamesh
    Chalhoub, Jean
    Singhania, Rohit
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1793 - S1794
  • [8] Patterns of Dose Escalation Amongst Patients with Ulcerative Colitis and Crohn's Disease Treated with Vedolizumab vs. Infliximab in the United States
    Khalid, Javaria Mona
    Raluy-Callado, Mireia
    Li, Qian
    Luo, Michelle
    Lasch, Karen
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S316 - S317
  • [9] Characteristics of Patients Treated With Vedolizumab for Inflammatory Bowel Disease in the United States
    Mody, Reema
    Chastek, Benjamin
    Patel, Haridarshan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S779 - S780
  • [10] Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States
    Chiorean, Michael
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Guerin, Annie
    Fan, Tao
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 877 - 885
12345